$0.8650
-0.0101-1.15%
Ult. Agg.: Oct 28, 9:56 AM
Cardiff Oncology (CRDF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.16 | $-0.13 | $-0.19 | $-0.20 |
| Actual | $-0.14 | $-0.18 | $-0.11 | $-0.17 |
| Surprise | +12.5% | -38.5% | +42.1% | +15.0% |
| Revenue | ||||
| Estimate | $68224 | $90000 | $114100 | $132858 |
| Actual | $104000 | $41000 | $243000 | $120000 |
| Surprise | +52.4% | -54.4% | +113.0% | -9.68% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.14 | $-0.13 | $-0.13 |
| Revenue | ||||
| Consensus | $91144 | $98288 | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.14 | $-0.16 | 12.5 % |
| Q1 | May 14, 2026 | $-0.18 | $-0.13 | -38.5 % |
| Q4 | Feb 24, 2026 | $-0.11 | $-0.19 | 42.1 % |
| Q3 | Nov 6, 2025 | $-0.17 | $-0.20 | 15.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $104.00K | $68.22K | 52.4 % |
| Q1 | May 14, 2026 | $41.00K | $90.00K | -54.4 % |
| Q4 | Feb 24, 2026 | $243.00K | $114.10K | 113.0 % |
| Q3 | Nov 6, 2025 | $120.00K | $132.86K | -9.68 % |